CN114939003A - Preparation method of bracket tube applied to ureter - Google Patents
Preparation method of bracket tube applied to ureter Download PDFInfo
- Publication number
- CN114939003A CN114939003A CN202210533147.1A CN202210533147A CN114939003A CN 114939003 A CN114939003 A CN 114939003A CN 202210533147 A CN202210533147 A CN 202210533147A CN 114939003 A CN114939003 A CN 114939003A
- Authority
- CN
- China
- Prior art keywords
- tube
- stent
- stent tube
- ureter
- reduced
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/02—Inorganic materials
- A61L31/022—Metals or alloys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/08—Materials for coatings
- A61L31/10—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/18—Materials at least partially X-ray or laser opaque
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M27/00—Drainage appliance for wounds or the like, i.e. wound drains, implanted drains
- A61M27/002—Implant devices for drainage of body fluids from one part of the body to another
- A61M27/008—Implant devices for drainage of body fluids from one part of the body to another pre-shaped, for use in the urethral or ureteral tract
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2002/048—Ureters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2210/0014—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof using shape memory or superelastic materials, e.g. nitinol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2210/0076—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof multilayered, e.g. laminated structures
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2240/00—Manufacturing or designing of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2240/001—Designing or manufacturing processes
- A61F2240/002—Designing or making customized prostheses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/12—Nanosized materials, e.g. nanofibres, nanoparticles, nanowires, nanotubes; Nanostructured surfaces
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Vascular Medicine (AREA)
- Surgery (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Cardiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Gastroenterology & Hepatology (AREA)
- Pulmonology (AREA)
- Inorganic Chemistry (AREA)
- Physics & Mathematics (AREA)
- Urology & Nephrology (AREA)
- Optics & Photonics (AREA)
- Otolaryngology (AREA)
- Anesthesiology (AREA)
- Hematology (AREA)
- Prostheses (AREA)
Abstract
Description
技术领域technical field
本发明涉及医疗设备制造技术领域,特别是一种输尿管应用的支架管制备方法。The invention relates to the technical field of medical equipment manufacturing, in particular to a method for preparing a stent tube for ureteral application.
背景技术Background technique
输尿管疾病(比如说良性前列腺增生症)是老年男性常见疾病,70岁人群中发病率高到60%。临床上主要表现为排尿困难,尿频,夜尿增加,严重者可以发生血尿和尿潴留,无法排尿。前列腺增生症目前的主要治疗方法是药物治疗和手术治疗以及放置支架管。支架管放置具体操作中,是把支架管植入人体的前列腺通道内,支架管能推开增生挤压的前列腺组织、扩大尿道的通路,缓解尿道压力,实现尿道完全通畅,其避免了实施手术及其并发症,是目前治疗前列腺增生排尿困难的最好选择。Ureteral diseases, such as benign prostatic hyperplasia, are common in older men, with a prevalence of as high as 60% in the 70-year-old. The main clinical manifestations are dysuria, frequent urination, increased nocturia, and in severe cases, hematuria and urinary retention may occur, and the inability to urinate. The current main treatments for BPH are drug therapy and surgery as well as stent placement. In the specific operation of stent placement, the stent tube is implanted into the prostate channel of the human body. The stent tube can push open the proliferative and squeezed prostate tissue, expand the passage of the urethra, relieve the pressure of the urethra, and achieve complete urethral patency, which avoids the need for surgery. It is currently the best choice for the treatment of dysuria due to benign prostatic hyperplasia.
现有的支架管虽然给输尿管疾病的治疗起到了技术支持,但是受到结构所限,或多或少还是存在一些技术问题,具体体现如下。其一:目前应用较为普遍的双J型输尿管用支架管没有解决输尿管支架管结晶阻塞和细菌感染的问题,限制了在病人体内的使用时间,通常只能作为2类医疗器械使用;其二:由于结构相对不合理支架管安装后在人体内容易产生滑移现象,对其造成不利影响;其三:植入输尿管后人体膀胱肾压力过高时,回传递到肾盂,会造成有害物质进入血液;其四:现有的技术是在支架管上采用单层防反流尾膜,但开闭时,形状变化会引起患部部位不适反应;其五:由于结构所限,会给病人造成一定的不适感且有发生阻塞的概率;其六:支架管的结构是编网结构,加工制造难度相对加大,且增加了生产费用支出;其六:生产打孔中容易造成刀头损坏。综上所述,现有的输尿管制造还存在很大的改进余地。Although the existing stent tube provides technical support for the treatment of ureteral diseases, due to the limitation of the structure, there are still some technical problems more or less, which are embodied as follows. One: The commonly used double-J-type ureteral stent does not solve the problems of crystal blockage and bacterial infection of the ureteral stent, which limits the use time in the patient's body, and can usually only be used as a Class 2 medical device; Second: Due to the relatively unreasonable structure of the stent tube, it is easy to slip in the human body after installation, which will adversely affect it; third: when the human bladder and kidney pressure is too high after implantation in the ureter, it will be transmitted back to the renal pelvis, which will cause harmful substances to enter the blood. Fourth: the existing technology is to use a single-layer anti-reflux tail film on the stent tube, but when opening and closing, the shape change will cause discomfort in the affected part; Discomfort and the probability of blockage; Sixth: The structure of the stent tube is a woven mesh structure, which is relatively more difficult to process and manufacture, and increases production costs; Sixth: Production drilling is easy to cause damage to the cutter head. In conclusion, there is still much room for improvement in existing ureteral manufacturing.
发明内容SUMMARY OF THE INVENTION
为了克服现有输尿管制造中,由于结构及加工工艺限制存在如背景所述弊端,本发明提供了在相关工艺共同作用下,降低了加工难度、制备出的成品放置在人体相应器官内后,能降低内部腔道沉积结晶阻塞、减少支架管表面结晶及感染、减少输尿管支架管滑移的概率、能对肾压起到保护作用、提高了导尿性的一种输尿管应用的支架管制备方法。In order to overcome the drawbacks described in the background due to the limitations of the structure and processing technology in the existing ureteral manufacture, the present invention provides that under the combined action of the related processes, the processing difficulty is reduced, and the prepared finished product can be placed in the corresponding organs of the human body. A method for preparing a stent for ureteral application, which can reduce the blockage of deposited crystals in the inner lumen, reduce the surface crystals and infection of the stent, reduce the probability of the ureteral stent slipping, protect the renal pressure, and improve the catheterization.
本发明解决其技术问题所采用的技术方案是:The technical scheme adopted by the present invention to solve its technical problems is:
一种输尿管应用的支架管制备方法,其特征在于包括如下工艺,A:使用PTFE薄膜作为支架管内部腔涂层,减少尿液中结晶阻塞支架管内侧的几率;B:用抗菌防结晶亲水溶液涂覆支架管表面,减少支架管表面结晶及感染的几率;C:改变支架管加工中的留置肾盂端猪尾定型时间及温度,使头端猪尾硬度较大,减少支架管发生滑移的概率,膀胱端采用软材料、提高人体适应性;D:输尿管后端采用双层TPU防反流膜,外层硬保持形状并减少形状改变引起病人体内的不适;E:支架管外层使用温敏TPU材料,提高用户舒适度;F:使用镍钛丝替代不锈钢丝作为支架管的制作材料,植入人体后在受到强力瞬态挤压后,可自行复原,减少造成阻塞的概率并降低特殊情况下支架管受压闭塞造成的危害;G:支架管整体镍材料采用螺旋结构,降低加工难度,缩短平均生产工时;H:通过螺旋结构变螺距,杜绝打孔刀头损坏几率,降低打孔工艺难度;I:支架管外层具有颜色能经X光显影、方便检查及置入人体。A method for preparing a stent tube for ureteral application, which is characterized by comprising the following processes: A: using a PTFE film as a coating of the inner cavity of the stent tube to reduce the probability that crystals in urine block the inner side of the stent tube; B: using an antibacterial anti-crystallization hydrophilic solution Coat the surface of the stent tube to reduce the probability of crystallization and infection on the surface of the stent tube; C: Change the time and temperature of the pigtail at the indwelling renal pelvis during the processing of the stent tube, so that the hardness of the head end pigtail is larger, and the probability of slippage of the stent tube is reduced, The bladder end is made of soft material to improve the adaptability of the human body; D: The back end of the ureter is made of double-layer TPU anti-reflux membrane, and the outer layer is hard to maintain the shape and reduce the discomfort caused by the shape change; E: The outer layer of the stent tube uses temperature-sensitive TPU material to improve user comfort; F: Use nickel-titanium wire instead of stainless steel wire as the material for the stent tube. After being implanted into the human body, it can recover by itself after being squeezed by a strong transient, reducing the probability of causing blockage and reducing special circumstances. Hazards caused by the pressure and occlusion of the stent tube; G: The overall nickel material of the stent tube adopts a spiral structure, which reduces the processing difficulty and shortens the average production time; H: The screw pitch is changed through the spiral structure to prevent the damage of the punching head and reduce the difficulty of the punching process. ; I: The outer layer of the stent tube has a color that can be visualized by X-ray, which is convenient for inspection and placement in the human body.
进一步地,所述工艺A中,使用PTFE薄膜厚度为20-50纳米。Further, in the process A, the thickness of the PTFE film is 20-50 nanometers.
进一步地,所述工艺B中,是从抗结晶,抑菌两方面改善表面涂层,亲水溶液厚度为40-70纳米。Further, in the process B, the surface coating is improved from two aspects of anti-crystallization and bacteriostasis, and the thickness of the hydrophilic solution is 40-70 nanometers.
进一步地,所述工艺F中,能减少造成阻塞的概率;降低特殊受压闭塞造成的危害。Further, in the process F, the probability of blocking can be reduced; the harm caused by special pressure blocking can be reduced.
进一步地,所述工艺H中,使待打孔处金属丝分布密度变低,提高打孔安全性。Further, in the process H, the distribution density of the metal wires at the place to be punched is reduced to improve the safety of punching.
进一步地,所述工艺H中,能根据目标客户留置体内的位置选择左旋或右旋反向,提高输尿管支架管导尿性。Further, in the process H, left-handed or right-handed inversion can be selected according to the indwelling position of the target client, so as to improve the catheterization of the ureteral stent.
本发明有益效果是:本发明结合相关制备工艺流程,降低了成品的加工难度、制备出的成品放置在人体相应器官内后,能降低支架管内部腔道沉积结晶阻塞、减少支架管表面结晶及感染、减少输尿管支架管滑移的概率、能对肾压起到保护作用、提高了导尿性。克服了现有技术中由于结构及制备工艺限制,会对输尿管支架管生产及应用带来的弊端。基于上述,本发明具有好的应用前景。The beneficial effects of the present invention are as follows: the present invention reduces the processing difficulty of the finished product in combination with the relevant preparation process flow, and after the prepared finished product is placed in the corresponding organs of the human body, it can reduce the blockage of deposition crystals in the inner lumen of the stent tube, reduce the surface crystallization of the stent tube and Infection, reducing the probability of ureteral stent slippage, protecting renal pressure, and improving catheterization. The invention overcomes the drawbacks in the prior art due to the limitation of the structure and the preparation process, which will bring about the production and application of the ureteral stent tube. Based on the above, the present invention has a good application prospect.
附图说明Description of drawings
图1是本发明制备的成品外形图。Fig. 1 is the outline drawing of the finished product prepared by the present invention.
图2是本发明是双层反流尾膜的结构示意图。Figure 2 is a schematic structural diagram of the double-layer reverse flow tail membrane of the present invention.
具体实施方式Detailed ways
图1、2所示,一种输尿管应用的支架管制备方法,(1):使用PTFE薄膜作为输尿管的支架管内部保护腔层,减少实际应用中粘液的结晶阻塞。(2):使用抗菌防结晶亲水溶液涂覆支架管表面、减少表面被尿液结晶及人体组织感染,减少复发率(资料显示,现有支架管使用后,临床中50%的病人在术后5~10年会再次复发,究其原因主要是留置期间,输尿管的支架管表面形成沉积结晶,直接或在拔出过程中刺破或拉开输尿管内黏膜,使得菌类可以直接附着到输尿管壁上,慢慢形成沉积;因此本发明从抗结晶,抑菌两方面改善表面涂层,能克服现有技术的缺点。As shown in Figures 1 and 2, a method for preparing a stent for ureteral application, (1): use a PTFE film as the inner protective cavity layer of the ureteral stent to reduce the crystallization blockage of mucus in practical applications. (2): Use an antibacterial and anti-crystal hydrophilic solution to coat the surface of the stent tube, reduce the infection of the surface by urine crystals and human tissue, and reduce the recurrence rate (data show that after the use of the existing stent tube, 50% of the patients in clinical practice will suffer from postoperative complications). It will recur in 5 to 10 years. The main reason is that during the indwelling period, deposition crystals form on the surface of the ureteral stent, which directly or during the extraction process pierces or pulls open the ureteral mucosa, so that the bacteria can directly attach to the ureteral wall. On the surface, the deposition is gradually formed; therefore, the present invention improves the surface coating from the two aspects of anti-crystallization and bacteriostasis, and can overcome the shortcomings of the prior art.
图1、2所示,一种输尿管应用的支架管制备方法,(3):改变支架管的留置肾盂端猪尾生产定型时间及温度,使头端猪尾硬度较大,减少支架管放置于人体内尿道内后发生滑移的概率;现有TPU高分子输尿管的支架管在人体尿液环境中充分接触每30天力学性能衰减到原来的5/4;相应的亦会对固定强度造成不利影响,故本发明提高肾盂端猪尾硬度,防止了位移及发生滑脱,且支架管的膀胱端较软提高了人体适应性。(4):采用防反流尾膜,提供肾压保护;实际情况下,支架管植入输尿管后膀胱肾压力过高时,会传递到肾盂,造成有害物质进入血液,因此需要防反流尾膜阻止压力传递,现有的做法是采用单层防反流尾膜,但应用中其开闭时,形状变化会引起人体组织部分不适反应,本发明设计双层TPU防反流膜,外层较硬保持形状减少形状改变对人体组织引起的不适,内层起到封闭开合的作用。(5):双层防反流尾膜,提高用户舒适度;(6):支架管外层使用温敏TPU材料,能提高用户舒适度。(7):改变留置膀胱端猪尾定型时间及温度,使尾端猪尾硬度较小,提高用户舒适度。As shown in Figures 1 and 2, a method for preparing a stent tube for ureteral application, (3): changing the production and shaping time and temperature of the pigtail at the indwelling renal pelvis end of the stent tube, so that the hardness of the pigtail at the head end is larger, and the stent tube is less placed in the human body. The probability of slippage in the urethra; the mechanical properties of the existing TPU polymer ureteral stents are fully contacted in the human urine environment and attenuate to 5/4 of the original every 30 days; Therefore, the present invention improves the hardness of the pigtail at the end of the renal pelvis, prevents displacement and slippage, and the bladder end of the stent tube is relatively soft to improve the adaptability of the human body. (4): The anti-reflux tail membrane is used to provide protection against renal pressure; in practice, when the bladder and kidney pressure is too high after the stent is implanted into the ureter, it will be transmitted to the renal pelvis, causing harmful substances to enter the blood, so it is necessary to prevent the reflux tail The membrane prevents pressure transmission. The existing practice is to use a single-layer anti-reflux tail membrane, but when it is opened and closed in application, the shape change will cause some discomfort in the human tissue. The present invention designs a double-layer TPU anti-reflux membrane, the outer layer The harder shape keeps the shape and reduces the discomfort caused by the shape change to the human tissue, and the inner layer plays the role of closing and opening. (5): Double-layer anti-reflux tail film to improve user comfort; (6): The outer layer of the stent tube is made of temperature-sensitive TPU material, which can improve user comfort. (7): Change the shaping time and temperature of the pigtail at the end of the bladder, so that the hardness of the pigtail at the tail end is smaller and the user comfort is improved.
图1、2所示,一种输尿管应用的支架管制备方法,(8):使用镍钛丝替代不锈钢丝作为主体材料,实际应用中,在受到强力瞬态挤压后,会自行复原,减少了造成阻塞的概率;并降低特殊情况下支架管受压闭塞造成的危害。(9):镍钛丝支架管采用螺旋结构,降低加工难度,缩短平均工时;卷曲弹簧状结构比现有支架管编制网状纺丝效率上要高很多。(10):在钛丝螺旋支架管需打孔处,螺旋变螺距,回避了孔刀头损坏,降低了孔工艺难度;卷曲弹簧状结构,制定段拉伸定型,使待打孔处金属丝分布密度变低,提高打孔安全性。(11):PTFE层有颜色能显影,上层透明,方便打孔工艺及在X光下植入人体尿道内。(12):镍钛丝有两种螺旋方向,根据目标客户留置期需要离开了选择左旋,或者右旋,能提高输尿管的支架管导尿性。本发明结合相关制备工艺流程,降低了加工难度、制备出的成放置在人体相应器官内后,能降低输尿管支架管内部腔道沉积结晶阻塞、减少支架管表面结晶及感染、减少输尿管支架管滑移的概率、能对肾压起到保护作用、提高了导尿性;克服了现有技术中由于结构及制备工艺限制,会对输尿管支架管生产及应用带来的弊端。As shown in Figures 1 and 2, a method for preparing a stent for ureteral application, (8): use nickel-titanium wire instead of stainless steel wire as the main material. It reduces the probability of causing obstruction; and reduces the harm caused by the compression and occlusion of the stent tube under special circumstances. (9): The nickel-titanium wire stent tube adopts a helical structure, which reduces the difficulty of processing and shortens the average working time; the coiled spring-like structure is much more efficient than the existing stent tube weaving mesh spinning. (10): In the place where the titanium wire spiral stent tube needs to be punched, the screw pitch is changed, which avoids the damage of the hole cutter head and reduces the difficulty of the hole process. The distribution density becomes lower and the punching safety is improved. (11): The PTFE layer has color and can be developed, and the upper layer is transparent, which is convenient for the drilling process and implantation in the human urethra under X-ray. (12): The nickel-titanium wire has two spiral directions. According to the needs of the target customer during the indwelling period, left-handed or right-handed is selected, which can improve the catheterization of the ureteral stent. Combined with the relevant preparation process, the invention reduces the difficulty of processing, and after the prepared product is placed in the corresponding organs of the human body, it can reduce the blockage of deposited crystals in the lumen of the ureteral stent, reduce the surface crystallization and infection of the stent, and reduce the sliding of the ureteral stent. It can protect the renal pressure, improve the catheterization, and overcome the disadvantages of the prior art due to the limitation of the structure and the preparation process, which will bring about the production and application of the ureteral stent.
以上显示和描述了本发明的基本原理和主要特征及本发明的优点,对于本领域技术人员而言,显然本发明限于上述示范性实施例的细节,而且在不背离本发明的精神或基本特征的情况下,能够以其他的具体形式实现本发明。因此,无论从哪一点来看,均应将实施例看作是示范性的,而且是非限制性的,本发明的范围由所附权利要求而不是上述说明限定,因此旨在将落在权利要求的等同要件的含义和范围内的所有变化囊括在本发明内。While the basic principles and main features and advantages of the present invention have been shown and described above, it will be apparent to those skilled in the art that the present invention is limited to the details of the above-described exemplary embodiments without departing from the spirit or essential characteristics of the present invention. In this case, the present invention can be implemented in other specific forms. Therefore, the embodiments are to be regarded in all respects as illustrative and not restrictive, and the scope of the invention is to be defined by the appended claims rather than the foregoing description, which are therefore intended to fall within the scope of the claims. All changes within the meaning and scope of the equivalents of , are included in the present invention.
此外,应当理解,虽然本说明书按照实施方式加以描述,但并非实施方式仅包含一个独立的技术方案,说明书的这种叙述方式仅仅是为清楚起见,本领域技术人员应当将说明书作为一个整体,实施例中的技术方案也可以经适当组合,形成本领域技术人员可以理解的其他实施方式。In addition, it should be understood that although this specification is described according to an embodiment, it does not mean that the embodiment only includes an independent technical solution. This description in the specification is only for the sake of clarity. Those skilled in the art should take the specification as a whole and implement the The technical solutions in the examples can also be appropriately combined to form other embodiments that can be understood by those skilled in the art.
Claims (6)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210533147.1A CN114939003A (en) | 2022-05-12 | 2022-05-12 | Preparation method of bracket tube applied to ureter |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210533147.1A CN114939003A (en) | 2022-05-12 | 2022-05-12 | Preparation method of bracket tube applied to ureter |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN114939003A true CN114939003A (en) | 2022-08-26 |
Family
ID=82907644
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202210533147.1A Pending CN114939003A (en) | 2022-05-12 | 2022-05-12 | Preparation method of bracket tube applied to ureter |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN114939003A (en) |
Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030171708A1 (en) * | 2002-03-07 | 2003-09-11 | Joseph Segura | Ureteral stent |
| US20040143209A1 (en) * | 2003-01-22 | 2004-07-22 | Liu Clifford M. | Ureteral stent configured for improved patient comfort and aftercare |
| US20120123527A1 (en) * | 2009-07-07 | 2012-05-17 | Cook Medical Technologies Llc | Hydrogel enhanced medical devices |
| CN204995963U (en) * | 2015-09-18 | 2016-01-27 | 深圳市库珀科技发展有限公司 | Ureteral stent suit |
| US20180147046A1 (en) * | 2015-05-19 | 2018-05-31 | Vascular Flow Technologies Limited | A stent |
| CN112107782A (en) * | 2020-10-09 | 2020-12-22 | 深圳市世格赛思医疗科技有限公司 | Ureteral stent |
| CN112386747A (en) * | 2017-06-02 | 2021-02-23 | 天津工业大学 | Ureteral stent tube with shape memory function and preparation method and application thereof |
| CN113382756A (en) * | 2018-11-30 | 2021-09-10 | 斯特拉塔卡系统有限公司 | Coated and/or impregnated ureteral catheter or stent and method of making same |
-
2022
- 2022-05-12 CN CN202210533147.1A patent/CN114939003A/en active Pending
Patent Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030171708A1 (en) * | 2002-03-07 | 2003-09-11 | Joseph Segura | Ureteral stent |
| US20040143209A1 (en) * | 2003-01-22 | 2004-07-22 | Liu Clifford M. | Ureteral stent configured for improved patient comfort and aftercare |
| US20120123527A1 (en) * | 2009-07-07 | 2012-05-17 | Cook Medical Technologies Llc | Hydrogel enhanced medical devices |
| US20180147046A1 (en) * | 2015-05-19 | 2018-05-31 | Vascular Flow Technologies Limited | A stent |
| CN204995963U (en) * | 2015-09-18 | 2016-01-27 | 深圳市库珀科技发展有限公司 | Ureteral stent suit |
| CN112386747A (en) * | 2017-06-02 | 2021-02-23 | 天津工业大学 | Ureteral stent tube with shape memory function and preparation method and application thereof |
| CN113382756A (en) * | 2018-11-30 | 2021-09-10 | 斯特拉塔卡系统有限公司 | Coated and/or impregnated ureteral catheter or stent and method of making same |
| CN112107782A (en) * | 2020-10-09 | 2020-12-22 | 深圳市世格赛思医疗科技有限公司 | Ureteral stent |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5871475A (en) | Catheter system | |
| US7507218B2 (en) | Stent with flexible elements | |
| US5269802A (en) | Prostatic stent | |
| Lam et al. | Update on ureteral stents | |
| CN201658735U (en) | locally dilated balloon catheter | |
| CN207401003U (en) | A kind of ureter bracket | |
| Smith | Percutaneous ureteral surgery and stenting | |
| CN112426616A (en) | Special ureteral stent for kidney transplantation | |
| CN101862500A (en) | locally dilated balloon catheter | |
| CN108785825B (en) | Part quick dissolving type anti-reflux ureteral stent | |
| CN209154828U (en) | A kind of dual firmness superslide J-type conduit | |
| CN114939003A (en) | Preparation method of bracket tube applied to ureter | |
| Lee et al. | Thermo-expandable intra-prostatic stent in the treatment of acute urinary retention in elderly patients with significant co-morbidities | |
| CN209108220U (en) | A kind of end is dissolvable to arrange double J pipe with line certainly | |
| CN208065565U (en) | Ureteral catheter with sacculus | |
| Garcia et al. | Intraurethral stent prosthesis in spinal cord injured patients with sphincter dyssynergia | |
| CN213821900U (en) | Exempt from novel comfortable type ureter support of operation being convenient for take out | |
| CN211024674U (en) | A ureteral stent device | |
| CN209519215U (en) | The rapid-dissoved anti-reflux ureter bracket in part | |
| CN116350869A (en) | Anti-reflux ureteral stent tube and use method thereof | |
| CN216439802U (en) | Anti-drop bacterinertness ureter support | |
| CN214970992U (en) | A new type of urethral dilator for assisted catheterization | |
| Abbas et al. | Pediatric Ureteral Stents | |
| CN209173194U (en) | urethral dilator | |
| CN114469466A (en) | Exempt from novel comfortable type ureter support of operation being convenient for take out |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |